Form 8-K · Current report
Align Technology 8-K, filed Oct 28, 2026
- Filed
- CIK
- 0001097149
- Accession no.
- 0001097149-26-000078
Summary
Align Technology's board appointed Jennifer L. Davis as CEO-elect and director effective November 2, 2026, and as president and CEO effective December 31, 2026, with Joseph M. Hogan retiring as president and CEO at that date and continuing as a strategic advisor under a one-year consulting agreement. Davis, formerly CEO of Procter & Gamble's health care business and an AbbVie board member since 2023, will receive a $1.3 million base salary, a 150% target bonus, equity awards and a $2 million signing bonus under her employment agreement.
Key points
- Davis's appointment as a director expands Align's board from ten to eleven members effective November 2, 2026.
- Hogan is expected to remain on the board until June 2027 as a non-executive, non-independent member, with re-election nomination conditioned on a prior irrevocable resignation after the June 2027 strategy meeting.
- Davis's one-time equity grants consist of market stock units valued at $9.9 million vesting over three years and restricted stock units valued at $6.6 million vesting over four years.
- Hogan will receive a $150,000 annual consulting fee, remain eligible for a 2026 annual cash incentive, and receive no new equity awards while his outstanding awards continue to vest.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. CEO Succession and Appointment of New Director On October 26, 2026, the Board of Directors (the “Board”) of Align Technology, Inc. (the “Company”) appointed Jennifer L. Davis as Chief Executive Officer-elect and director of the Company, effective November 2, 2026 (the “Commencement Date”), and as President and Chief Executive Officer (“CEO”) of the Company, effective December 31, 2026. Joseph M. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.